texas oncology more breakthroughs. more victories
Some of our cancer centers are experiencing issues.  View More Important Notifications x

ESMO 2021: A New Era of Next-Generation Therapies in HER2-Positive Breast Cancer

Publication: OncologyTube

Michelina Cairo, M.D., medical oncologist at Texas Oncology–Houston Memorial City discusses the results of the randomized phase III DESTINY-Breast03 study and it's possible impact on HER2-positive breast cancer patients. This research was presented at the 2021 European Society of Medical Oncology (ESMO) Congress.

View the full story at OncologyTube or listen to the OncologyTube Podcast.

Related Physicians

Related Cancer Centers